Home/Filings/4/0001437749-22-009165
4//SEC Filing

McClung David 4

Accession 0001437749-22-009165

CIK 0000925741other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 9:17 PM ET

Size

7.0 KB

Accession

0001437749-22-009165

Insider Transaction Report

Form 4
Period: 2022-04-14
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-04-14+50,34597,150 total
  • Award

    Stock Option (right to buy)

    2022-04-14+60,00060,000 total
    Exercise: $1.49Exp: 2032-04-14Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
  • [F2]The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.

Issuer

BioCardia, Inc.

CIK 0000925741

Entity typeother

Related Parties

1
  • filerCIK 0001686155

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 9:17 PM ET
Size
7.0 KB